<DOC>
	<DOCNO>NCT02670525</DOCNO>
	<brief_summary>This research study seek gain new knowledge Recurrent , Refractory , High Risk Leukemias child young adult . This study evaluate use specialize test call leukemia profiling . Once profile perform , result evaluate expert panel physician , scientist pharmacist . This may result recommendation specific cancer therapy clinical trial call matched target therapy ( MTT ) . The result leukemia profile , applicable , MTT recommendation communicate participant 's primary oncologist .</brief_summary>
	<brief_title>Matched Targeted Therapy For High-Risk Leukemias</brief_title>
	<detailed_description>This study determine whether possible use profiling result determine match targeted therapy patient leukemia . It describe range mutation find patient leukemia type profiling , describe clinical outcome patient receive match targeted therapy . Our tissue organ make cell . Cancer occur molecule normally control cell growth damage . The damage result unchecked cell growth cause tumor , collection cancer cell . The damage refer alteration . There different type cancer-causing alteration . Genes part cell contain instruction tell cell make right protein grow work . Genes compose DNA letter spell instruction . By participate study , participant 's leukemia cell test cancer cause alteration . This test call leukemia profiling . The leukemia profiling perform use bone marrow blood already obtain clinical test . Alternately , profile may do leukemia cell plan obtain part routine clinical care .</detailed_description>
	<mesh_term>Leukemia</mesh_term>
	<criteria>Age â‰¤ 30 year study entry Diagnosis : Patients enrol one two cohort base diagnosis : Cohort 1 : Relapsed/refractory leukemia Acute lymphoblastic leukemia , first great relapse Acute myeloid leukemia , first great relapse Leukemia refractory induction chemotherapy Other recurrent leukemia Cohort 2 : New diagnosis Acute myeloid leukemia , new diagnosis ( exclude acute promyelocytic leukemia ( APL ) ) New diagnosis infant MLLrearranged ALL low hypodiploid ( &lt; 40 chromosome ) ALL Rare leukemia e.g. , JMML , leukemia ambiguous lineage Secondary leukemia Pathologic Criteria Histologic confirmation leukemia time diagnosis recurrence Specimen Samples Sufficient leukemia specimen available profile diagnosis recurrence OR bone marrow aspirate/blood draw/pheresis/other fresh sample patient leukemia cell plan clinical care anticipate allow collection minimum specimen test . Insufficient leukemia specimen available profile diagnosis recurrence ; bone marrow evaluation/blood draw/other leukemia cell sample NOT plan obtain clinical care ; peripheral blast percentage &lt; 20 % AND clinical blood draw plan .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>30 Years</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>Recurrent , Refractory , High Risk Leukemias</keyword>
	<keyword>Matched target therapy</keyword>
</DOC>